Send us Feedback

Bruker BioSciences (BRKR)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

BRKR » Topics » Note 5-Accounts Receivable

These excerpts taken from the BRKR 10-K filed Mar 16, 2009.

Note 7—Accounts Receivable

        The following is a summary of trade accounts receivable at December 31, (in millions):

 
   2008   2007  

Gross accounts receivable

   $ 177.3   $ 191.3  

Allowance for doubtful accounts

     (5.4 )   (6.1 )
           
 

Accounts receivable, net

   $ 171.9   $ 185.2  
           

Note 7—Accounts Receivable



        The following is a summary of trade accounts receivable at December 31, (in millions):








































































 
 2008  2007  

Gross accounts receivable

 $177.3 $191.3 

Allowance for doubtful accounts

  (5.4) (6.1)
      
 

Accounts receivable, net

 $171.9 $185.2 
      




These excerpts taken from the BRKR 10-K filed Mar 17, 2008.

Note 5—Accounts Receivable

        The following is a summary of trade accounts receivable at December 31, (in thousands):

 
   2007
   2006
  
Gross accounts receivable   $ 116,828   $ 82,014  
Allowance for doubtful accounts     (1,890 )   (2,410 )
   
 
 
  Accounts receivable, net   $ 114,938   $ 79,604  
   
 
 

Note 5—Accounts Receivable



        The following is a summary of trade accounts receivable at December 31, (in thousands):




























































 
 2007
 2006
 
Gross accounts receivable $116,828 $82,014 
Allowance for doubtful accounts  (1,890) (2,410)
  
 
 
 Accounts receivable, net $114,938 $79,604 
  
 
 




This excerpt taken from the BRKR 10-K filed Mar 15, 2007.

Note 5—Accounts Receivable

The following is a summary of trade accounts receivable at December 31, (in thousands):

 

 

2006

 

2005

 

Gross accounts receivable

 

$

82,014

 

$

71,723

 

Allowance for doubtful accounts

 

(2,410

)

(3,810

)

Accounts receivable, net

 

$

79,604

 

$

67,913

 

 

This excerpt taken from the BRKR 8-K filed Dec 15, 2006.
Note 5—Accounts Receivable

The following is a summary of trade accounts receivable at December 31, (in thousands):

 

 

2005

 

2004

 

Gross accounts receivable

 

$

71,723

 

$

72,082

 

Allowance for doubtful accounts

 

(3,810

)

(2,988

)

Accounts receivable, net

 

$

67,913

 

$

69,094

 

 

This excerpt taken from the BRKR 8-K filed Sep 14, 2006.

3.              Accounts Receivable

The following is a summary of trade accounts receivable (in thousands):

 

 

2005

 

2004

 

Gross accounts receivable

 

$

14,638

 

$

11,599

 

Allowance for doubtful accounts

 

(470

)

(296

)

Accounts receivable, net

 

$

14,168

 

$

11,303

 

 

This excerpt taken from the BRKR 10-K filed Mar 14, 2006.
Note 4—Accounts Receivable

The following is a summary of trade accounts receivable at December 31, (in thousands):

 

 

2005

 

2004

 

Gross accounts receivable

 

$

57,084

 

$

60,484

 

Allowance for doubtful accounts

 

(3,340

)

(2,692

)

Accounts receivable, net

 

$

53,744

 

$

57,792

 

 

This excerpt taken from the BRKR 10-K filed Mar 31, 2005.

Note 4—Accounts Receivable

        The following is a summary of trade accounts receivable at December 31, (in thousands):

 
   2004
   2003
  
Gross accounts receivable   $ 60,484   $ 52,065  
Allowance for doubtful accounts     (2,692 )   (1,932 )
   
 
 
  Accounts receivable, net   $ 57,792   $ 50,133  
   
 
 

EXCERPTS ON THIS PAGE:

10-K (2 sections)
Mar 16, 2009
10-K (2 sections)
Mar 17, 2008
10-K
Mar 15, 2007
8-K
Dec 15, 2006
8-K
Sep 14, 2006
10-K
Mar 14, 2006
10-K
Mar 31, 2005

RELATED TOPICS for BRKR:

"Note 5-Accounts Receivable" elsewhere:

Affymetrix (AFFX)
BIO RAD LABORATORIES INC (BIO)
Cognex (CGNX)
FARO Technologies (FARO)
FEI Company (FEIC)
FLIR Systems (FLIR)
IRIS International (IRIS)
Nanometrics (NANO)
Qiagen N.V. (QGEN)
Rudolph Technologies (RTEC)
Sypris Solutions (SYPR)
Zygo (ZIGO)
Allied Motion Technologies (AMOT)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki